GPhC appoints Gisela Abbam as new chair

The General Pharmaceutical Council (GPhC) has appointed Gisela Abbam as its new chair, it has announced.

breaking
Gisela Abbam
Ms Abbam will officially start her new role on March 14

The Privy Council appointed Ms Abbam “after a robust selection process, which was scrutinised by the Professional Standards Authority”, the regulator wrote in an announcement this morning (February 16).

Ms Abbam will bring “a wealth of experience in delivering change in the health and life sciences sector” to her new role, which she will formally take on from March 14.

Previous roles

Before joining the GPhC, Ms Abbam was chair of the British Science Association, a role she took on in January 2019.

She also “worked in collaboration with governments, the World Health Organisation, the United Nations, and other multilateral organisations to improve health outcomes for people across the world”, the GPhC wrote.

Commenting on her appointment, Ms Abbam said she looks “forward to leading the council to achieve its vision of safe and effective pharmacy care at the heart of healthier communities”.

“COVID-19 highlighted the increased role of pharmacists, pharmacy technicians and pharmacies in providing clinical services”, she continued.

“Effective standards and regulation can help pharmacy to provide more support to patients and the public at large,” she said.

Who is she succeeding?

Ms Abbam will take over from outgoing chair Nigel Clarke, who has completed his maximum term as chair, having been in the role since 2014.

“Gisela is joining the GPhC at an exciting time of major changes in both pharmacy and health regulation,” Mr Clarke said.

“I am sure her vast experience in healthcare will help the GPhC drive forward the aims set out in our Vision 2030”, he added, “and bring a real focus on the difference we want to make for patients and the public”.

Sign in or register for free

Latest from News

Sebco coal tar scalp ointment appointed by DHSC to support current shortages

 • comment

Due to shortages in coal tar scalp ointment, the DHSC has asked the manufacturer of an equivalent product - Sebco - to provide increased stock levels to support patients during this time.

Pharmacies to boost naloxone stock amid ‘sudden’ overdose spike

 
• By 
 • comment

Pharmacies in Scotland have been asked to ensure they have the “appropriate stock” of naloxone – a medicine used to reverse the effects of an opiate overdose – following an “increase in sudden collapse” due to overdoses.

Cuts and commissioning: What does NHSE’s axing mean for ICBs?

 
• By 
 • comment

As the dust settles on the announcement that NHS England (NHSE) is set for the scrapheap, questions on what a 50% headcount cut means for local commissioners remain…

More from Business

breaking news

IN FULL: Boots’ parent company sold in $24bn private equity deal

 
• By 
 • comment

Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.

Jhoots accounts: Shareholder funds tumble while debts soar

 
• By 
 • comment

Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.